As of 2024-12-12, the Relative Valuation of Oncternal Therapeutics Inc (ONCT) is (217.85) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.53 USD, the upside of Oncternal Therapeutics Inc based on Relative Valuation is -41468.4%.
The range of the Relative Valuation is (212.59) - (228.71) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 25.0x | 18.4x |
| Forward P/E multiples | 12.6x - 19.6x | 18.9x |
| Fair Price | (212.59) - (228.71) | (217.85) |
| Upside | -40470.2% - -43531.2% | -41468.4% |
| Date | P/E |
| 2024-12-02 | -0.05 |
| 2024-11-29 | -0.06 |
| 2024-11-27 | -0.06 |
| 2024-11-26 | -0.06 |
| 2024-11-25 | -0.06 |
| 2024-11-22 | -0.10 |
| 2024-11-21 | -0.10 |
| 2024-11-20 | -0.10 |
| 2024-11-19 | -0.09 |
| 2024-11-18 | -0.09 |
| 2024-11-15 | -0.10 |
| 2024-11-14 | -0.10 |
| 2024-11-13 | -0.10 |
| 2024-11-12 | -0.10 |
| 2024-11-11 | -0.11 |
| 2024-11-08 | -0.11 |
| 2024-11-07 | -0.12 |
| 2024-11-06 | -0.15 |
| 2024-11-05 | -0.14 |
| 2024-11-04 | -0.13 |
| 2024-11-01 | -0.13 |
| 2024-10-31 | -0.12 |
| 2024-10-30 | -0.13 |
| 2024-10-29 | -0.13 |
| 2024-10-28 | -0.12 |
| 2024-10-25 | -0.13 |
| 2024-10-24 | -0.13 |
| 2024-10-23 | -0.15 |
| 2024-10-22 | -0.15 |
| 2024-10-21 | -0.18 |
| 2024-10-18 | -0.12 |
| 2024-10-17 | -0.12 |
| 2024-10-16 | -0.12 |
| 2024-10-15 | -0.10 |
| 2024-10-14 | -0.09 |
| 2024-10-11 | -0.10 |
| 2024-10-10 | -0.10 |
| 2024-10-09 | -0.10 |
| 2024-10-08 | -0.11 |
| 2024-10-07 | -0.11 |
| 2024-10-04 | -0.11 |
| 2024-10-03 | -0.11 |
| 2024-10-02 | -0.11 |
| 2024-10-01 | -0.11 |
| 2024-09-30 | -0.11 |
| 2024-09-27 | -0.12 |
| 2024-09-26 | -0.12 |
| 2024-09-25 | -0.12 |
| 2024-09-24 | -0.13 |
| 2024-09-23 | -0.12 |